(Q34035006)

30 July 2017

1 reference

title

Insulin-like growth factor I in hypercatabolic states (English)

1 reference

30 July 2017

1 reference

Gore DC

1

1 reference

30 July 2017

publication date

1 April 1998

1 reference

Growth Hormone & I G F Research

30 July 2017

published in

1 reference

30 July 2017

volume

8 Suppl B

1 reference

30 July 2017

page(s)

115-116

1 reference

Effects of recombinant human growth hormone on donor-site healing in severely burned children

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Effect of exogenous growth hormone on glucose utilization in burn patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Mode of action of pituitary growth hormone on target cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

The rationale for the use of recombinant human growth hormone and insulin-like growth factor-I for catabolic conditions in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Insulinlike growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Clinical uses of insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

Hormonal and nutritional regulation of IGF-I and its binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980033-6

7 January 2021

10.1016/S1096-6374(98)80033-6

Identifiers

DOI

1 reference

release_kfnhhngbsjgr7ndrxrse6havb4

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kfnhhngbsjgr7ndrxrse6havb4

24 November 2022

mapped directly with Wikidata item

1 reference